creb3l3b Antibody

What is CREB3L3 and what cellular functions does it perform?

CREB3L3 (cAMP Responsive Element Binding Protein 3-Like 3) is a 461 amino acid single-pass type II membrane protein primarily localized to the endoplasmic reticulum (ER). This protein functions as a transcription factor that responds to ER stress through a mechanism involving cleavage and subsequent translocation to the nucleus. Once in the nucleus, CREB3L3 activates genes involved in the unfolded protein response and acute phase response pathways, highlighting its critical role in cellular stress management .

CREB3L3 contains several important structural features that enable its function:

• Leucine zipper domain

• KDEL-like sequence

• Basic leucine zipper (bZIP) domain for DNA binding capabilities

The protein typically operates as a dimer and exists in three isoforms resulting from alternative splicing, which diversifies its functional roles in cellular processes . Research has also shown that CREB3L3 is underexpressed in hepatocellular carcinoma, suggesting it may function as a tumor suppressor .

What detection methods can CREB3L3 antibodies be used for in laboratory research?

CREB3L3 antibodies can be employed across multiple detection methods, making them versatile tools for research applications. The table below outlines common applications based on available antibody products:

For optimal results in each application, researchers should validate antibody performance in their specific experimental systems. For example, polyclonal antibodies targeting AA 201-300 of CREB3L3 have been successfully used in multiple applications, suggesting this region contains accessible epitopes across various experimental conditions .

What species reactivity should researchers expect with commercial CREB3L3 antibodies?

When selecting CREB3L3 antibodies, species reactivity is an important consideration for experimental design. Based on available product information:

Researchers working with zebrafish models should note that while specific creb3l3b antibodies aren't detailed in the search results, there is information about the zebrafish creb3l3l gene (ZDB-GENE-040426-2942), which is orthologous to human CREB3 . For zebrafish studies, antibody cross-reactivity testing would be essential before proceeding with experiments .

How should researchers properly store and handle CREB3L3 antibodies to maintain activity?

While specific storage conditions for CREB3L3 antibodies weren't explicitly detailed in the search results, standard antibody handling practices apply:

• Temperature: Store antibodies at -20°C for long-term storage or at 4°C for short-term use

• Aliquoting: Divide concentrated antibodies into single-use aliquots to avoid repeated freeze-thaw cycles

• Buffer conditions: Maintain recommended buffer compositions (typically PBS with preservatives)

• Light sensitivity: For fluorescent conjugates like AbBy Fluor® 594 CREB3L3 antibodies, protect from light exposure to prevent photobleaching

• Avoiding contamination: Use sterile technique when handling antibody solutions

For conjugated antibodies, such as the CREB3L3 antibody with AbBy Fluor® 594, additional precautions may be necessary to preserve the fluorophore integrity during storage and use .

How can researchers validate the specificity of CREB3L3 antibodies in their experimental systems?

Validating antibody specificity is critical for generating reliable research data. For CREB3L3 antibodies, consider these methodological approaches:

• Positive and negative control tissues/cells: Use tissues known to express CREB3L3 (such as liver) as positive controls and compare with tissues that don't express the protein

• Blocking peptide experiments: Pre-incubate the antibody with the immunizing peptide (e.g., synthetic peptide derived from human CREB-H for the rabbit polyclonal antibody) before application to samples

• Knockout/knockdown validation: Compare staining patterns between wild-type samples and those where CREB3L3 expression has been eliminated or reduced

• Alternative antibody comparison: Test multiple antibodies targeting different epitopes of CREB3L3 (e.g., AA 201-300, AA 244-274, AA 371-460) and compare staining patterns

• Western blot analysis: Confirm antibody detects a protein of the expected molecular weight (approximately 50-55 kDa for CREB3L3, though this may vary by isoform)

This multifaceted approach to validation ensures confidence in subsequent experimental findings.

What considerations are important when designing multiplex immunofluorescence experiments with CREB3L3 antibodies?

Multiplex immunofluorescence allows simultaneous detection of multiple targets, but requires careful planning:

• Fluorophore selection: Choose fluorophores with minimal spectral overlap. CREB3L3 antibodies are available with various conjugates including AbBy Fluor® 594, AbBy Fluor® 647, and AbBy Fluor® 680, allowing flexibility in experimental design

• Panel design: Consider CREB3L3's subcellular localization when designing panels. Since CREB3L3 localizes to the ER membrane in unstressed cells and translocates to the nucleus during stress, co-staining with organelle markers may provide valuable contextual information

• Sequential staining protocols: For complex panels or when using multiple antibodies from the same host species, sequential staining with appropriate blocking steps may be necessary

• Titration: Determine optimal antibody concentration through titration experiments to minimize background while maintaining specific signal

• Controls for spectral unmixing: Include single-stained controls for each fluorophore to facilitate accurate spectral unmixing during analysis

• Fixation compatibility: Ensure fixation methods are compatible with all antibodies in the multiplex panel. CREB3L3 antibodies have been validated for both cultured cells and paraffin-embedded sections

How do different fixation methods affect CREB3L3 antibody performance in immunohistochemistry and immunofluorescence?

Fixation methods can significantly impact epitope accessibility and antibody binding. For CREB3L3 detection:

• Paraffin embedding: CREB3L3 antibodies have been validated for use with paraffin-embedded sections, suggesting that formalin fixation preserves detectable epitopes

• Frozen sections: Some CREB3L3 antibodies are also validated for frozen section immunohistochemistry (IHC-fro), providing an alternative when antigen retrieval in paraffin sections is problematic

• Cultured cells: For cultured cells, milder fixation methods (e.g., 4% paraformaldehyde for 10-15 minutes) often preserve CREB3L3 epitopes while maintaining cellular architecture

• Antigen retrieval considerations: For paraffin sections, heat-induced epitope retrieval in citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) should be optimized to maximize CREB3L3 detection

• Membrane permeabilization: Since CREB3L3 is an ER membrane protein that can translocate to the nucleus, adequate permeabilization is essential for antibody access to all cellular compartments

Each fixation method presents different trade-offs between structural preservation and epitope accessibility that should be empirically determined for specific experimental goals.

What metabolic engineering approaches can be used to optimize antibody-cell conjugation for CREB3L3 studies?

Advanced research involving CREB3L3 may benefit from antibody-cell conjugation (ACC) technologies. Current methodologies include:

• Metabolic sugar engineering: This approach introduces an azide moiety (such as 9-azido N-acetylneuraminic acid methyl ester) onto cell surfaces, creating cells with surface azides. The antibody is then modified with DBCO-PEG4-NHS ester to form antibody-DBCO. These components can be coupled via azide-alkyne click chemistry, creating stable antibody-cell conjugates

• Chemoenzymatic methods: This alternative strategy uses enzyme-mediated oxidation of tyrosine-labeled antibodies to create reactive intermediates that can be coupled to cell surface proteins. This approach has been demonstrated with nanobodies (derived from camel immunoglobulins) and offers a simple, efficient conjugation method

• Optimization considerations: When applying these methods to CREB3L3 antibodies, researchers should consider:

  • The impact of chemical modifications on antibody binding affinity

  • Potential interference with CREB3L3 epitope recognition

  • Cell viability following conjugation procedures

  • Spatial orientation of the conjugated antibody to ensure epitope accessibility

These methodologies provide powerful tools for creating novel experimental systems to study CREB3L3 biology in cellular contexts.

What are common troubleshooting strategies for non-specific binding with CREB3L3 antibodies?

Non-specific binding can compromise experimental results. When using CREB3L3 antibodies, consider these troubleshooting approaches:

• Optimize antibody concentration: Titrate the antibody to find the optimal concentration that maximizes specific signal while minimizing background

• Improve blocking conditions: Test different blocking agents (BSA, normal serum, commercial blocking solutions) and increase blocking time

• Increase washing stringency: Use higher salt concentrations or mild detergents in wash buffers, and increase the number and duration of washes

• Pre-adsorption: Pre-adsorb the antibody with tissues or cell lysates from species that may cause cross-reactivity

• Secondary antibody controls: Include controls omitting primary antibody to identify non-specific binding from secondary antibodies

• Isotype controls: For monoclonal antibodies like the mouse IgG2a kappa CREB3L3 (E-2) antibody, include appropriate isotype controls

• Alternative antibody selection: If problems persist, consider testing antibodies targeting different epitopes of CREB3L3 (e.g., AA 201-300 vs. AA 371-460)

Methodical troubleshooting can significantly improve signal specificity and experimental reliability.

How can researchers optimize Western blot protocols for detecting different CREB3L3 isoforms?

Detecting multiple CREB3L3 isoforms requires optimized Western blot protocols:

• Gel percentage selection: Use lower percentage gels (7-10%) to better separate high molecular weight proteins, or gradient gels to resolve multiple isoforms simultaneously

• Sample preparation optimization:

  • For membrane-bound full-length CREB3L3: Include non-ionic detergents in lysis buffers

  • For nuclear cleaved forms: Use nuclear extraction protocols

  • To preserve all isoforms: Add protease inhibitors to prevent degradation

• Transfer conditions: For larger isoforms, extend transfer time or use wet transfer methods instead of semi-dry

• Antibody selection strategy: Choose antibodies that recognize epitopes present in all isoforms (e.g., AA 201-300) or use multiple antibodies targeting different regions to distinguish isoforms

• Controls for isoform identification:

  • Positive controls from tissues known to express specific isoforms

  • Treatment conditions that alter isoform ratios (e.g., ER stress inducers)

  • Migration standards appropriate for the expected molecular weights

• Exposure optimization: Use incremental exposure times to capture both abundant and less abundant isoforms without saturation

This methodical approach facilitates the detection and quantification of different CREB3L3 isoforms.

How can CREB3L3 antibodies be used to study ER stress responses in different disease models?

CREB3L3's role in ER stress response makes it a valuable target for disease research:

• Stress induction time course studies: Track CREB3L3 cleavage and nuclear translocation following treatment with ER stress inducers (e.g., tunicamycin, thapsigargin) using fractionation and Western blotting with CREB3L3 antibodies

• Co-localization analysis: Use fluorescently conjugated CREB3L3 antibodies (e.g., AbBy Fluor® 594) in combination with markers for ER (e.g., calnexin) and nucleus (e.g., DAPI) to visualize translocation during stress responses

• Disease model applications:

  • Hepatocellular carcinoma: Investigate CREB3L3 expression levels and subcellular localization, given its reported underexpression in this cancer

  • Metabolic disorders: Examine CREB3L3 activation in models of lipid metabolism dysfunction

  • Inflammatory conditions: Study CREB3L3's role in acute phase response regulation

• Comparative model systems: Compare CREB3L3 function across species using cross-reactive antibodies (human, mouse, rat) or ortholog-specific antibodies (e.g., for zebrafish creb3l3l)

• Drug screening applications: Use CREB3L3 immunostaining as a readout for compounds that modulate ER stress responses

These applications leverage CREB3L3 antibodies as tools for understanding fundamental disease mechanisms.

What considerations are important when using CREB3L3 antibodies in zebrafish and other non-mammalian model systems?

Working with zebrafish and other non-mammalian models presents unique challenges:

• Ortholog identification: Zebrafish have a creb3l3l gene (ZDB-GENE-040426-2942) that is orthologous to human CREB3, but researchers should verify the appropriate ortholog for their studies

• Expression pattern knowledge: In zebrafish, creb3l3l is expressed in central nervous system, liver, notochord, sensory system, and yolk syncytial layer, which should inform experimental design and tissue selection

• Cross-reactivity testing: Commercially available antibodies may exhibit cross-reactivity with zebrafish proteins, but this should be experimentally verified:

  • Western blot validation with zebrafish tissue lysates

  • Peptide competition assays

  • Comparison with known expression patterns

• Fixation optimization: Non-mammalian tissues may require modified fixation protocols to preserve epitopes while maintaining tissue architecture

• Developmental timing considerations: Expression of creb3l3l may vary throughout development, requiring temporal sampling strategies

• Genetic approaches: Complement antibody studies with genetic approaches (morpholinos, CRISPR) to validate findings

Researchers should conduct preliminary validation studies to ensure antibody performance in non-mammalian systems before proceeding with extensive experiments.

What emerging technologies might enhance the utility of CREB3L3 antibodies in biomedical research?

Several cutting-edge approaches show promise for advancing CREB3L3 research:

• Antibody-cell conjugation technologies: Building on current ACC methods, researchers could develop CREB3L3 antibody-cell conjugates for targeted delivery in therapeutic applications, especially given CREB3L3's potential tumor suppressor role in hepatocellular carcinoma

• Super-resolution microscopy applications: Combining fluorescently conjugated CREB3L3 antibodies with techniques like STORM or PALM could reveal previously unappreciated details about CREB3L3's subcellular localization and trafficking

• Proximity labeling approaches: Conjugating CREB3L3 antibodies with enzymes like APEX2 or TurboID could enable identification of protein interaction networks in living cells

• Antibody engineering: Developing smaller antibody formats (nanobodies, scFvs) against CREB3L3 could improve tissue penetration and enable new applications like intravital imaging

• Single-cell applications: Adapting CREB3L3 antibodies for single-cell proteomics techniques would allow analysis of CREB3L3 expression heterogeneity within tissues

These technological advances have the potential to significantly expand our understanding of CREB3L3 biology and its role in health and disease.